Company patents
Evalve, Inc.
Evalve, Inc. demonstrates a clear focus on core medical device technologies, with Implants & Prosthetics representing 77.5% of its portfolio and Medical Diagnostics & Surgery at 65.7%. While patenting in Implants & Prosthetics has stabilized so far in 2026 with 19 patents, it's surprising to see a significant decline in Medical Diagnostics & Surgery, down 31.6% year-over-year from 2025, suggesting a potential shift in priorities despite its large portfolio share.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
102 US filings (since 2023) · 3 categories · 6 themes
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
Patents
Showing 1-10 of 17
Catheter-based Intervention Devices